发明人杨光,罗永刚,高志强. "Method for the Synthesis of Ceritinib Impurity 44" [P]. 中国发明专利, 专利号 CN 112829178 B, 授权公告日 2025-10-16.
发明人高志强,杨光,胡光. "A Process for Preparing High-Purity Ceritinib Impurity 44" [P]. 中国发明专利, 专利号 CN 108157417 A, 授权公告日 2022-02-19.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质44 in Pharmaceutical Formulations". J. Nat. Prod., 2019, 1469, 8469-8485.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质44 as an Impurity". Environ. Sci. Technol., 2024, 2355, 9810-9831.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 44 Using HRMS and NMR". Molecules, 2019, 2143, 8951-8967.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质44 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2010, 360, 7057-7075.